Xcout Intel
Imagene AI
Imagene AI is a pioneering company in the field of AI-driven medical diagnostics, leveraging deep learning to analyze biological samples.
Subscribe to see Imagene AI’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Imagene AI at a glance
Imagene AI is a biotech/ai company headquartered in Israel, founded in 2020. Its most recent funding round, Series B, raised $23M in July 2025. Xcout tracks 13 named people at Imagene AI, including Emre Gültürk (Chief Operating Officer).
Imagene AI leadership
- Emre GültürkChief Operating Officer
- Dean BitanCEO & Co-founder
- Shahar PoratCTO & Co-founder
- Jonathan ZalachCDSO & Co-founder
- Brian Laffin, PhDVP of Translational & Clinical Strategy
- Inbal Gazy, PhDVP of Science & Regulatory Strategy
7 more named people on record for Imagene AI, with roles, board committees and tenure — see the full roster →
Imagene AI funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $23M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Imagene AI competitors
A few of Imagene AI's closest competitors — see the full list of competitors and alternatives →
Coreline Soft is a medical AI company specializing in chest CT image analysis and early disease detection. The firm develops artificial intelligence-powered software solutions to support healthcare providers in medical imaging diagnostics.
PreciseDx, Inc. provides an AI-powered platform called OncoIntelligence and its specific product, PreciseBreast, to analyze tissue samples and determine breast cancer recurrence risk. The company serves oncologists, surgeons, pathologists, payors, and patients by offering objective risk stratification and phenotype insights within hours.
Entelai develops artificial intelligence solutions for clinical diagnosis, aimed at healthcare professionals, medical institutions, and patients. Its technology is designed to improve diagnostic accuracy, optimize medical workflows, and facilitate online medical prescriptions and studies.
Mindpeak is an artificial intelligence company based in Hamburg, Germany, that builds AI solutions for precision medicine and pathology.
Harrison.ai is an Australian healthcare technology company that develops clinically validated artificial-intelligence systems for medical imaging and other diagnostic applications. It works with healthcare providers and specialist clinical partners to support radiologists, pathologists, and other clinicians in diagnosis and workflow.
AEYE Health provides FDA-cleared, autonomous artificial intelligence solutions for diagnostic screening, specializing in instant diabetic retinopathy diagnosis using handheld and tabletop retinal cameras. The company serves primary care physicians, endocrinologists, and teleretinal screening providers by enabling on-the-spot diagnoses that eliminate the need for specialist referrals.
Get Imagene AI's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Imagene AI in Xcout Intel
- 13 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access